基于可行性注册表的随机对照试验协议,调查针对中风的量身定制后续服务 (A-LISTS)
Dominique A Cadilhac1,2, Andrew G Ross3,4, Kathleen L Bagot3,5
1Stroke Theme, The Florey Institute of Neuroscience and Mental Health, Heidelberg, VIC, Australia. dominique.cadilhac@monash.edu.
Pilot and feasibility studies
|July 31, 2024
概括
这项研究将评估一项新的由医院主导的中风幸存者的随访服务,以改善他们的生活质量并减少医院再入院. 试验将对服务进行评估.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 医疗保健服务研究 医疗服务研究
背景情况:
- 脑卒中显著影响长期的身体和认知功能.
- 幸存者经常经历未满足的健康需求,包括疼痛和抑郁症.
- 有效的后续护理对于管理中风后的健康状况和预防再入院至关重要.
研究的目的:
- 评估新的,量身定制的,医院主导的中风幸存者随访服务的可行性,可接受性,潜在有效性和成本.
- 评估干预对未满足需求和功能独立性的影响.
- 为未来的大规模疗效试验和实施策略提供信息.
主要方法:
- 一个基于注册的随机受控试验,来自澳大利亚中风临床注册表的100名参与者.
- 在中风后90-180天报告极端健康问题 (EQ-5D-3L) 的参与者被随机 (1:1) 分给干预或常规护理.
- 评估结果包括可行性,可接受性,有效性 (EQ-5D-3L,未满足需求,功能独立性) 和成本影响,并进行过程和经济评估.
主要成果:
- 主要可行性结果包括试验完成率和服务利用率.
- 可接受性将通过临床医生和参与者的满意度来衡量.
- 二次结果将决定干预对健康问题,未满足需求,再接收和功能状态的有效性.
结论:
- 这项研究将为设计和实施中风后续服务的障碍和促进者提供关键的见解.
- 结果将为资源分配提供信息,并指导未来的全功率有效性试验.
- 这项研究旨在优化中风后的护理和改善幸存者的结果.
更多相关视频
07:35Author Spotlight: Rehabilitation of Stroke Patients With a Digital Occupational Training System
Published on: December 29, 2023
1.2K
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
550
相关概念视频
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...